61 related articles for article (PubMed ID: 38649719)
1. Role of drug catabolism, modulation of oncogenic signaling and tumor microenvironment in microbe-mediated pancreatic cancer chemoresistance.
Capula M; Perán M; Xu G; Donati V; Yee D; Gregori A; Assaraf YG; Giovannetti E; Deng D
Drug Resist Updat; 2022 Sep; 64():100864. PubMed ID: 36115181
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms of drug resistance of pancreatic ductal adenocarcinoma at different levels.
Du J; Gu J; Li J
Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32677676
[TBL] [Abstract][Full Text] [Related]
3. A novel multidrug-resistant cell line from a Chinese patient with pancreatic ductal adenocarcinoma.
Tang H; Miao X; Yu C; Chai C; Su Y; Li L; Yi J; Ye Z; Miao L; Wang Z; Zhang H; Xu H; Zhou W
Sci Rep; 2024 Apr; 14(1):9259. PubMed ID: 38649719
[TBL] [Abstract][Full Text] [Related]
4. Pooled CRISPR screening in pancreatic cancer cells implicates co-repressor complexes as a cause of multiple drug resistance via regulation of epithelial-to-mesenchymal transition.
Ramaker RC; Hardigan AA; Gordon ER; Wright CA; Myers RM; Cooper SJ
BMC Cancer; 2021 May; 21(1):632. PubMed ID: 34049503
[TBL] [Abstract][Full Text] [Related]
5. Intrinsic gemcitabine resistance in a novel pancreatic cancer cell line is associated with cancer stem cell-like phenotype.
Hu G; Li F; Ouyang K; Xie F; Tang X; Wang K; Han S; Jiang Z; Zhu M; Wen D; Qin X; Zhang L
Int J Oncol; 2012 Mar; 40(3):798-806. PubMed ID: 22076649
[TBL] [Abstract][Full Text] [Related]
6. TRIM11 suppresses ferritinophagy and gemcitabine sensitivity through UBE2N/TAX1BP1 signaling in pancreatic ductal adenocarcinoma.
Shang M; Weng L; Xu G; Wu S; Liu B; Yin X; Mao A; Zou X; Wang Z
J Cell Physiol; 2021 Oct; 236(10):6868-6883. PubMed ID: 33629745
[TBL] [Abstract][Full Text] [Related]
7. Simvastatin attenuates macrophage-mediated gemcitabine resistance of pancreatic ductal adenocarcinoma by regulating the TGF-β1/Gfi-1 axis.
Xian G; Zhao J; Qin C; Zhang Z; Lin Y; Su Z
Cancer Lett; 2017 Jan; 385():65-74. PubMed ID: 27840243
[TBL] [Abstract][Full Text] [Related]
8. TM4SF1 Promotes Gemcitabine Resistance of Pancreatic Cancer In Vitro and In Vivo.
Cao J; Yang J; Ramachandran V; Arumugam T; Deng D; Li Z; Xu L; Logsdon CD
PLoS One; 2015; 10(12):e0144969. PubMed ID: 26709920
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of GV1001 with gemcitabine/capecitabine in previously untreated patients with advanced pancreatic ductal adenocarcinoma having high serum eotaxin levels (KG4/2015): an open-label, randomised, Phase 3 trial.
Jo JH; Kim YT; Choi HS; Kim HG; Lee HS; Choi YW; Kim DU; Lee KH; Kim EJ; Han JH; Lee SO; Park CH; Choi EK; Kim JW; Cho JY; Lee WJ; Moon HR; Park MS; Kim S; Song SY
Br J Cancer; 2024 Jan; 130(1):43-52. PubMed ID: 37903909
[TBL] [Abstract][Full Text] [Related]
10. The Lin28b/Wnt5a axis drives pancreas cancer through crosstalk between cancer associated fibroblasts and tumor epithelium.
Shu Z; Fan M; Tu B; Tang Z; Wang H; Li H; Li H; Yuan M; Bai J; Huo S; Wang L; Zhu WG; Wang W; Liu X; Shu S; Zhao Y
Nat Commun; 2023 Oct; 14(1):6885. PubMed ID: 37898598
[TBL] [Abstract][Full Text] [Related]
11. Chemoresistance in pancreatic ductal adenocarcinoma: Overcoming resistance to therapy.
Bhoopathi P; Mannangatti P; Das SK; Fisher PB; Emdad L
Adv Cancer Res; 2023; 159():285-341. PubMed ID: 37268399
[TBL] [Abstract][Full Text] [Related]
12. Establishment and characterization of a new human ampullary carcinoma cell line, DPC-X1.
Xu H; Chai CP; Miao X; Tang H; Hu JJ; Zhang H; Zhou WC
World J Gastroenterol; 2023 May; 29(17):2642-2656. PubMed ID: 37213400
[TBL] [Abstract][Full Text] [Related]
13. RHOJ controls EMT-associated resistance to chemotherapy.
Debaugnies M; Rodríguez-Acebes S; Blondeau J; Parent MA; Zocco M; Song Y; de Maertelaer V; Moers V; Latil M; Dubois C; Coulonval K; Impens F; Van Haver D; Dufour S; Uemura A; Sotiropoulou PA; Méndez J; Blanpain C
Nature; 2023 Apr; 616(7955):168-175. PubMed ID: 36949199
[TBL] [Abstract][Full Text] [Related]
14. Humanized mouse models for immuno-oncology research.
Chuprin J; Buettner H; Seedhom MO; Greiner DL; Keck JG; Ishikawa F; Shultz LD; Brehm MA
Nat Rev Clin Oncol; 2023 Mar; 20(3):192-206. PubMed ID: 36635480
[TBL] [Abstract][Full Text] [Related]
15. GBCdb: RNA expression landscapes and ncRNA-mRNA interactions in gallbladder carcinoma.
Guo L; Xiang Y; Dou Y; Yin Z; Xu X; Tang L; Yu J; Wang J; Liang T
BMC Bioinformatics; 2023 Jan; 24(1):12. PubMed ID: 36624399
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
